Skip to main content
Premium Trial:

Request an Annual Quote

The DNA Sell

Miinome, Minneapolis-based startup, envisions a marketplace in which companies could advertise to people based upon their DNA sequences. The pitch, as MIT's Technology Review puts it, could be: "Do you carry the genetic variants associated with lactose intolerance? Here, Lactaid has a coupon for you."

Founders Paul Saarinen and Scott Fahrenkrug discussed this DNA-based marketing at South by Southwest last year. "The marketplace is getting close to making this a reality,” Fahrenkrug said at the time, according to Social Media Today. "You’re leaving DNA everywhere, since you shed one million cells every day."

They are, Tech Review says, envisioning this company as an opt-in service.

However, interpreting DNA sequences remains a challenge — going from a certain sequence to a propensity for buying garden gnomes (or enjoying spicy food, as Tech Review says) isn't quite within range yet.

But James Ostheimer, another Miinome cofounder, says it's coming. He envisions people linking up their genetic information to their Twitter or Facebook accounts, which could then be mined to find such associations.

"Scientifically, that sounds like a stretch. But commercially it might not be," Tech Review adds.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.